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Abstract 
We designed a novel 6-point electrochemical impedance spectroscopy (EIS) sensor with 15 
combinations of permutations for the 3-D mapping and detection of metabolically active 
atherosclerotic lesions. Two rows of 3 stretchable electrodes circumferentially separated by 120° 
were mounted on an inflatable balloon for intravascular deployment and endoluminal 
interrogation. The configuration and 15 permutations of 2-point EIS electrodes allowed for deep 
arterial penetration via alternating current (AC) to detect varying degrees of lipid burden with 
distinct impedance profiles (Ω). By virtue of the distinctive impedimetric signature of metabolically 
active atherosclerotic lesions, a detailed impedance map was acquired, with the 15 EIS 
permutations uncovering early stages of disease characterized by fatty streak lipid accumulation in 
the New Zealand White rabbit model of atherosclerosis. Both the equivalent circuit and statistical 
analyses corroborated the 3-D EIS permutations to detect small, angiographically invisible, 
lipid-rich lesions, with translational implications for early atherosclerotic disease detection and 
prevention of acute coronary syndromes or strokes. 
Key words: Electrochemical Impedance Spectroscopy, 3-D Mapping, Atherosclerosis. 
Introduction 
Electrochemical Impedance Spectroscopy (EIS) is 
the macroscopic representation of the electric field 
and current density distribution within the specimen 
being tested. EIS characterizes the dielectric 
properties of blood vessels and lipid-rich plaques 
[1-3]. Applying quasi-electrostatic limits to Maxwell’s 
equations, the field distribution is described as 
follows [4]: 
          (Eq. 1) 
where .  and  denote the 
conductivity and permittivity of the sample, 
respectively, ω the angular frequency, , and φ 
the voltage distribution. Current density, , is 
calculated with the distribution of electric field, . 
Thus, electrical impedance of the sample, z, according 
to Maxwell’s equations, is expressed as follows: 
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where  denotes the electrode-tissue interface 
area, and Δφ the voltage difference across the two 
electrodes of the EIS sensor. Intravascular ultrasound 
(IVUS)-guided EIS sensors detect atherosclerotic 
lesions associated with oxidative stress in fat-fed New 
Zealand White (NZW) rabbits [5]. Specifically, vessel 
walls harboring oxidized low density lipoprotein 
cholesterol (oxLDL) exhibit distinct EIS values [3]. 
However, atherosclerotic lesions are often eccentric 
and multiple. To detect these lesions, we sought to 
develop a novel 6-point electrode configuration for 
comprehensive 3-D endoluminal interrogation of 
angiographically invisible atherosclerosis.  
OxLDL [6] in atherosclerotic lesions display 
distinct frequency-dependent electrical and 
dielectrical properties [7-8]. We developed concentric 
bipolar electrodes to assess elevated EIS signals in 
oxLDL-rich lesions from human coronary, carotid, 
and femoral arteries [1]. By deploying the flexible and 
stretchable bipolar electrodes to the aorta of NZW 
rabbits, we demonstrated a significant increase in 
impedance magnitude in oxLDL-rich plaques [3]. We 
further established a 2-point micro-electrode 
configuration to allow for deep intraplaque 
penetration via alternating current (AC) [9]. The 
frequency sweep from 10 to 300 kHz generated an 
increase in capacitance, providing distinct changes in 
impedance (Ω) in relation to varying degrees of aortic 
intraplaque lipid burden [9]. 
To advance intravascular EIS interrogation for 
flexible 3-D endoluminal plaque detection, we hereby 
propose a 6-point electrode configuration to enable 15 
alternating EIS permutations of 2-point electrode 
arrays for comprehensive impedance mapping and 
detection of lipid-rich atherosclerotic lesions. The 
individual electrode configuration was identical in 
each row, where three electrodes were 
circumferentially and equidistantly positioned. In 
addition to optimal contact with the endoluminal 
surface, this new 6-point configuration enabled 15 
different pairs of electrodes to provide 3-D 
interrogation of the endoluminal area. We 
demonstrated the capability of flexible 3-D EIS 
sensors to detect angiographically invisible early 
atherosclerotic lesions in different aortic segments 
from NZW rabbits on high-fat diet-induced 
hypercholesterolemia. The 3-D EIS measurements 
were in close agreement with the equivalent circuit 
model for aortas consisting of vessel tissue, 
atherosclerotic lesion, blood and perivascular fat. 
Statistical analysis corroborated the 3-D EIS 
permutations for early atherosclerosis detection, with 
clinical implications to prevent acute coronary 
syndromes or strokes. 
Materials and Methods 
Sensor design and fabrication 
The newly designed 6-point EIS sensor featured 
six individual electrodes that were circumferentially 
mounted on an inflatable balloon (Fig. 1). The 
individual electrodes were identical in dimensions 
(600 µm × 300 µm) and connected to an impedance 
analyzer (Gamry Series G 300 potentiostat, PA) that 
was installed in a desktop computer. Specifically, 
there were three electrodes embedded in each row, 
and the distance between the two rows was 2.4 mm 
(Fig. 1b). Within each layer, the 3 electrodes were 
equidistantly placed around the circumference of the 
balloon at 120° separation from each other (Fig. 1c). 
This 6-point configuration optimized the contact with 
the endoluminal surface for EIS measurements. 
Furthermore, the 6 electrodes allowed for 15 different 
combinations of 2-point electrodes for 3-dimensional 
endoluminal interrogation. 
To micro-fabricate the EIS sensors, we first 
acquired flexible polyimide electrodes 
(FPCexpress.com, Ontario, CA) with a nominal length 
of up to 1 meter to bypass the need for interconnects 
that are required between electrode pads and wirings 
[9]. These flexible electrodes have been 
pre-constructed according to the pattern shown in Fig. 
1 using the following process: a copper layer (12 µm) 
was deposited onto the polyimide substrate (12 µm) 
through electroplating, followed by selective chemical 
etching of the lithographically-defined patterns via 
the dry film photoresist (Fig. 2). A second layer of 
polyimide (12 µm) was added to cover the majority of 
the copper area using a lamination process. The 
copper area that eventually became the 
electrode/contact pad was left uncovered. Finally, a 
layer of Au/Ni (50 nm/2000 nm) was added through 
electroless-nickel-immersion-gold (ENIG) process. 
To develop the catheter-based device for 
intravascular deployment, we mounted the inflatable 
balloon (9 mm in length, 1 mm diameter under 
deflation and ~3 mm diameter under inflation, 
Ventiona Medical, NH) on the terminal end of the 
catheter (40 cm in length) (Vention Medical, NH). 
Miniature holes were designed to enable balloon 
inflation. A pair of tantalum foils (1×1 mm, Advanced 
Research Materials, Oxford, UK) was incorporated to 
both ends of the balloon as a radiopaque marker, and 
was secured by a short segment of heat-shrink tube 
(in green) (Vention Medical, NH). The front end of the 
flexible electrodes was mounted onto the balloon by 
the silicone adhesive (Henkel, CT), and the rest of the 
electrodes and the catheter were encapsulated with 
the insulating heat-shrink tube 40cm long, amber 
(Vention Medical, NH). The electrical connection to 
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the impedance analyzer (Gamry Series G 300 
potentiostat) was made via the soldering wires on the 
exposed contact pads at the terminal end of the 
flexible electrodes. The prototype of the 6-point sensor 
was comprised of the radio-opaque markers, the 
inflatable balloon, and the electrodes packaged 
around the catheter (Fig. 1a-d). A mechanical pump 
(Atrion Medical Products Inc., Arab, AL) was 
connected to the end of the catheter to induce balloon 
inflation. 
 
 
Figure 1. Design and deployment of the balloon-inflatable electrodes. (a) Photographs reveal the device prototype with zoomed-in views of 
balloon-inflation, providing details of the individual electrodes, balloon, and radio-opaque markers. (b) Top and (c) side views provide the dimensions of the 6-point 
sensor upon balloon-inflation. (d) A 3-dimensional schematic illustration of the 6-point electrochemical impedance spectroscopy (EIS) device highlights the 
endoluminal deployment strategy upon balloon-inflation (∅ 3mm). The inset shows the device under the balloon-deflated state (∅ 1mm) prior to deployment. The 
individual electrodes (six in total) are in contact with the endoluminal surface upon balloon-inflation. 
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Figure 2. Fabrication process of flexible electrodes. (a) Deposition of copper layer and patterning of dry-film photoresist; (b) etching of copper layer; (c) 
deposition of another polyimide layer and exposing sensor electrodes and contact pad; (d) plating of Au/Ni layer. (e) Schematic of the final device assembly. 
 
Equivalent electrical circuits 
Equivalent circuit models were developed to 
analyze the electrochemical impedance of 
atherosclerotic lesions at 3 distinct segments of the 
aorta (Fig. 3a-d) in the setting of balloon inflation and 
deflation (Fig. 3e, f). A cross-sectional perspective of 
the circuit configuration provides the operational 
principle underlying electrode-tissue interface for the 
endoluminal EIS interrogation. Four main types of 
tissue contribute to the aggregated impedance values; 
namely, blood, aortic wall, atherosclerotic plaque and 
perivascular fat circumscribing the vessel. In this 
context, a simple circuit block was first applied to 
generalize the impedimetric behavior of the 
individual tissues, consisting of a parallel circuit with 
two paths: 1) a resistive element (R1) in series with a 
capacitive element (C) to model the cells; 2) a pure 
resistive element (R2) to model the extracellular 
materials (red frame in Fig. 3g) [10]. We further 
modeled the electrode-tissue interface using the 
constant phase element (CPE) to take into account the 
non-linear double layer capacitance behavior. The 
impedance of the interface can be expressed as: 
            (Eq. 3) 
Where Y denotes the empirical admittance value, 
and a a constant between 0 and 1, representing the 
non-ideal interface effects.  
When the balloon was deflated, blood was 
included as the primary component (Zblood) in the 
circuit model as other tissues were shielded by the 
presence of blood in contact with the electrodes (Fig. 
3g). When the balloon was inflated, the endoluminal 
surface was in contact with the electrodes. As a result, 
all of the tissue types contributed to the path of the 
current flow, accounting for the parallel circuit 
configuration for the blood, plaque, vessel wall 
(aorta), and perivascular fat  
( ) (Fig. 3h).  
Animal model 
All animal studies were approved by the UCLA 
Office of Animal Research. Analyses were conducted 
in n=4 control rabbits fed a chow diet and n=5 
age-matched high-fat fed NZW male rabbits [11]. 
High-fat animals were placed on a 1.5% cholesterol 
and 6.0% peanut oil diet (Harlan laboratory) for 8 
weeks prior to harvesting. Animals were anesthetized 
with isofluorane gas, endotracheally intubutated and 
placed on a mechanical ventilator. A femoral 
cut-down was performed and a 4-French arterial 
sheath placed in the common femoral artery. Under 
fluoroscopic guidance (Siemens Artis Zeego with 
robotic arm) and iodinated contrast dye injection, the 
EIS sensor was advanced for in vivo interrogation of 
the distal abdominal aorta (site no. 1), followed by the 
aorta at the level of renal artery bifurcation (site no. 2), 
and finally at the level of the thoracic aorta (site no. 3). 
(Fig. 3a-d). Following animal harvesting, aortic 
samples from the 3 sites were sent for histological 
analyses. In the adopted scheme of high-fat feeding, 
these 3 anatomic sites corresponded to areas with 
trace atherosclerosis, or fatty streaks (abdominal 
aorta), and mild plaque (thoracic aorta) by histology.  
1
( )CPE a
Z
Y jω
=
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Figure 3. In vivo sensor deployment and equivalent circuit modeling. The EIS sensor, identified on angiography by the proximal and distal markers, was 
deployed at 3 levels of the aorta (a), namely the thoracic aorta (b), the abdominal aorta at the level of renal artery bifurcation (c), and the distal abdominal aorta (d). 
The radiopaque markers made of tantalum (highlighted on the still angiograms by the black circle pointed to by the yellow arrows) permit the identification of the 
exact position of the device within the aorta. A cross-sectional perspective of the deflated (e) and inflated (f) balloon in the aorta shows specific electrodes to perform 
the endoluminal EIS measurement. The equivalent circuit includes the blood as primary circuit component upon balloon-deflation (g). The equivalent circuit further 
includes the aorta, plaque, blood, and perivascular fat all as the circuit components upon balloon-inflation (h). Legend. C: capacitive element. CPE: constant phase 
element. DM: distal sensor marker. Y: nominal capacitance value, 0<a<1. PM: proximal sensor marker. R: resistive element. S: sheath.  
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EIS measurement 
EIS measurement was conducted along the 
aorta, namely, abdominal aorta proximal to the aortic 
bifurcation, abdominal aorta at the level of the renal 
artery bifurcation, and thoracic aorta. The device with 
radiopaque markers was placed at these pre-selected 
segments of the aorta via invasive angiography that 
was performed during fluoroscopy to mark the exact 
position of the endoluminal EIS measurements. 
During balloon inflation, a constant pressure at ~10 
psi (pounds per square inch) was applied through a 
mechanical pump to establish contact with the 
endoluminal surface. EIS measurements were 
conducted using the Gamry system (Gamry Series G 
300 potentiostat, PA, USA). At each interrogation site, 
two replicates of each fifteen permutations were 
performed. AC signals with peak-to-peak voltages of 
50 mV and frequencies ranging from 1 – 300 kHz were 
delivered at each site. The impedance magnitudes 
were acquired at 10 data points per frequency decade.  
Histology 
After euthanasia, rabbits were perfused through 
the left ventricle with normosaline followed by 4% 
paraformaldehyde. Following fixation, aortic 
segments which had been identified in vivo by the 
radiopaque markers and interrogated during invasive 
angiography, were marked based on anatomic 
landmarks, excised, and samples sent to the CVPath 
Institute (Gaithersburg, MD) for further processing 
and staining. Following cryosectioning, samples were 
stained with hematoxylin and eosin and oil-Red-O for 
neutral lipids. Atherosclerotic areas identified by 
oil-Red-O were quantified using image J software 
(National Institutes of Health, Bethesda, MD).  
Statistical analyses 
To test for differences in impedance values, the 
Brown-Forsythe test was used to determine 
significance across groups, and Dunnett’s test was 
used for multiple comparisons and correction of 
multiple testing. Impedance values were further 
compared using the Mann-Whitney test for 
differences in medians, and the Kolmogorov-Smirnov 
test for differences in global value distributions. 
GraphPad version 6 was used to perform the 
statistical analyses. A P-value < 0.05 was considered 
significant. 
Results 
Intravascular deployment for EIS 
permutations 
Impedimetric interrogation was demonstrated in 
the thoracic aorta, abdominal aorta at the level of the 
renal artery bifurcation, and abdominal aorta 
proximal to the aortic bifurcation (Fig. 3a-d). Prior to 
the EIS measurements, angiographic images were 
obtained to localize the EIS sensors as demarcated by 
the radiopaque tantalum pairs. Invasive angiography 
was unable to detect early atherosclerotic lesions [12] 
in high-fat diet fed rabbits (Fig. 3b-d). A 
representative schematic of the intravascular sensor 
with deflated (Fig. 3e) and inflated (Fig. 3f) balloon is 
shown. The equivalent circuit includes the blood as 
primary circuit component upon balloon-deflation 
(Fig. 3g, Table S1). The equivalent circuit further 
includes the aorta, plaque, blood, and perivascular fat 
all as the circuit components upon balloon-inflation 
(Fig. 3h, Table S2).  
EIS mapping 
The 6-point electrode configuration enabled the 
demonstration of 15 EIS permutations (3+6+6) 
consisting of 3 2-point electrodes that were vertically 
linked between the two rows (Fig. 4a), 6 2-point 
electrodes that were linked circumferentially within 
rows (Fig. 4b), and 6 2-point electrodes that were 
cross-linked diagonally between the two rows (Fig. 
4c). This novel combination of 15 permutations paved 
the way for flexible 3-D interrogation and 
impedimetric mapping of the arterial segment over 3 
rings, or sub-segments, as illustrated (Fig. 4d-f). For 
the 3-D mapping, each color represents impedance 
values using a distinct electrode permutation (Fig. 4g), 
with lighter colors indicating lower impedances and 
darker colors higher impedances, as illustrated using 
a logarithmic scale. This user-friendly readout permits 
rapid clinical impedance interpretation of lesion 
types, detection of clinically silent atherosclerosis, and 
physician adoption based on usability.  
EIS measurements  
Representative real-time EIS measurements of 
impedance and phase are compared among the three 
segments of the aorta and correlated with histological 
findings (Fig. 5). Histology staining with oil-Red-O for 
atherosclerotic lesions supported the changes in EIS in 
response to the eccentric plaques from the thoracic 
aorta to the renal bifurcation and distal abdominal 
aorta (Fig. 5a-c). Early lesions, also known as fatty 
streaks, stained positive for intra-lesion neutral lipids 
by oil-Red-O (Fig. 5b). The sweeping frequency 
ranged from 1 – 300 kHz within which the impedance 
decreased monotonously across conditions. 
Differences in impedance were most significant at 1 
kHz (Fig. 5d-f). In the 3-D impedance map, lighter 
colors (yellow) were observed in control aortas (Fig. 
5g), intermediate colors (yellow, light brown) in fatty 
streaks (Fig. 5h), and darker colors (dark brown, 
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black) were present in the atherosclerotic plaques (Fig. 
5i). Furthermore, increasing delays in phase were 
identified with lesion progression from control (Fig. 
5j) to fatty streak (Fig. 5k) to mild plaque (Fig. 5l). The 
behavior of the EIS measurements was reflective of 
the heterogeneous composition of the atherosclerotic 
lesions.  
Equivalent circuit modeling 
Equivalent circuits were modeled to predict 
changes in EIS in response to balloon deflation and 
inflation (Fig. 3). The model parameters (as shown in 
Fig. 3) were numerically calculated by using a simplex 
algorithm available in the Gamry Echem Analyst 
software. Curve fitting was performed by 
incorporating the model parameters, namely; blood, 
vessel tissue, plaque, and perivascular fat. The 
theoretical curve fittings were in agreement with the 
experimental impedance (Ω) (Fig. 6a) and phase (°) 
measurements (Fig. 6b) during balloon deflation and 
inflation. Under the deflation state, the electrodes 
were in contact with the highly conductive blood, and 
the model parameters for the vessel tissue, lipid-rich 
plaques, and perivascular fat were electrically 
shielded for our equivalent circuit model (Fig. 3e, g, 
and Fig. 6a, b). Under the inflation state, the electrodes 
were in contact with the endoluminal surface and/or 
plaque, plus the additional model parameters from 
the vessel wall (Fig. 3f, h and Fig. 6a, b). The constant 
phase element can be described by the two variables Y 
and a. Our fitting results in both balloon deflated and 
inflated condition for Y/a are 321 nS·sa / 0.691 (where 
n=nano, S=Siemens, and s=seconds) and 248 nS·sa / 
0.659, respectively, which indicates there is no 
significant distinction between the two scenarios in 
terms of contact impedance. A Bode diagram 
comparison of the two different constant phase 
elements is presented in the supplementary 
information (Fig. S1) to show the behavior of the 𝑍𝑍𝐶𝐶𝐶𝐶𝐶𝐶. 
The value of a not being equal to 1 verifies the 
non-ideal capacitive behavior the electrode-tissue 
interface. The fitting results of other resistance and 
capacitance values are available in the supplementary 
information (Table S1), as well as a physical model to 
compare the circuit model fitting with reported 
conductivity and permittivity of different tissues.  
 
 
Figure 4. 3-D EIS mapping using the 15 permutations of the 6-point device. There are 6 electrodes on the device and the individual pairs of electrodes are 
connected by the solid/dotted lines, each representing one permutation. The design of the 6-point EIS sensor into 2 rows, or rings, of 3-point electrodes permits 3 
sets of long axis (vertical) interrogations (a), 6 sets of short axis (horizontal) interrogations (b), and 6 sets of diagonal interrogations (c) to create analysis of three 
arterial rings (d-f). (g) 3-D mapping of a reconstructed aortic segment with atherosclerosis highlights the 15 (3+6+6) distinct permutations of the EIS impedance 
measurements with corresponding color scale.  
 Theranostics 2017, Vol. 7, Issue 9 
 
 
http://www.thno.org 
2438 
Data analysis of 3-D EIS measurements 
From each aortic interrogation point, the 15 
permutations obtained at 1 kHz are displayed as the 
medians and the 2 extreme values (minimum – 
maximum) of the impedance range. These 
demonstrated a tight spread of values in control 
aortas, with a median impedance of 13.79 kΩ and a 
narrow range of global values ranging from a 
minimum of 5.22 kΩ to a maximum of 19.13 kΩ. Fatty 
streaks identified in the abdominal aorta at the level of 
renal artery bifurcation area or proximal to the aortic 
bifurcation demonstrated a median (17.75 kΩ) and 
range of values (minimum 5.79 – maximum 77.05 kΩ) 
intermediate to values in control segments and to 
values in mild plaque segments from the thoracic 
aorta (median 58.32 kΩ, minimum 30.86 kΩ, 
maximum 161.74 kΩ) (Fig. 6c). There was a significant 
difference across groups (P < 0.001), which was 
maintained by the pair-wise comparisons with 
correction for multiple testing. Comparing control to 
fatty streak, there was a significant difference in 
impedance medians (P = 0.016) and value 
distributions (P = 0.024). This difference was further 
accentuated when comparing control to mild 
atherosclerotic plaque (P < 0.001 for differences in 
both medians and value distributions). The 
impedance differences between fatty streaks and mild 
atherosclerotic plaques were also highly significant (P 
< 0.001 for differences in both medians and value 
distributions).  
 
 
Figure 5. EIS measurements and corresponding histology. Hematoxylin & eosin (H&E) staining was used for arterial wall and oil-Red-O for the lipid-laden 
atherosclerotic lesions to validate the EIS impedance measurements in control aortas (a, d), in fatty streaks from abdominal aortas (b, e), and in mild atherosclerotic 
plaques from the thoracic aorta (c, f). Eccentric plaques developed in the New Zealand White rabbits on high-fat diet in the thoracic aorta area (c, solid arrows), 
whereas much smaller, early atherosclerotic lesions, or fatty streaks, developed in the two abdominal sites (b, dotted arrows). Corresponding examples of the 
impedance magnitude obtained from the 15 interrogations in response to the sweeping frequency from 1 – 300 kHz are presented in logarithmic scale (d-f). The 
reconstruction of the 15 permutation measures are represented in 3-D color coded impedance maps, visually demonstrating differences between control (g), fatty 
streak (h), and mild atherosclerotic plaque (i). Corresponding phase plots are also presented in logarithmic scale (j-l). Scale bar: 1mm.  
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Figure 6. Comparison between theoretical and experimental data. Representative data fitting was performed under balloon-deflation and -inflation (a, b). A 
simplex algorithm in the Gamry Echem Analyst software was used to demonstrate the EIS measurements by applying the two equivalent circuit models (Fig. 3g, h). The 
fitting curves (solid lines) are in agreement with the experimental measurements (dotted lines) for impedance (a) and phase (b). In vivo data obtained at a frequency 
of 1kHz demonstrates significant differences in the median and range (min – max) of impedance values by condition (c). Legend. *P = 0.016 medians control vs. fatty 
streak. **P = 0.024 value distributions control vs. fatty streak. †P < 0.001 medians control vs. mild atherosclerotic plaque. ‡P < 0.001 value distributions control vs. 
mild atherosclerotic plaque. §P < 0.001 medians fatty streak vs. mild atherosclerotic plaque. ║P < 0.001 value distributions fatty streak vs. mild atherosclerotic plaque.  
 
Discussion 
The presented novel 6-point configuration 
advances disease detection to flexible 3-D 
interrogation of early atherosclerotic lesions that 
harbor distinct electrochemical properties otherwise 
invisible by current imaging modalities such as 
invasive angiography. Atherosclerosis is a chronic 
inflammatory disease of the arterial wall resulting 
from a complex interplay between heritability [13], 
environmental factors [14], intestinal microbiota [15], 
biomechanical forces [16], and other causes. 
Atherosclerosis develops over decades [17] with 
evidence of early lesions, or fatty streaks, present in 
autopsy series of young adults who died in their early 
20’s [18]. The end result of the advanced stages of the 
pathobiology of atherosclerosis remains a leading 
cause of mortality and morbidity worldwide through 
clinical manifestations such as acute coronary 
syndromes or strokes [19]. Invasive coronary 
angiography is considered the gold standard of 
coronary artery disease determination. Whereas this 
technique permits visualization of established 
atherosclerotic plaques, it does not have the 
necessary spatial resolution to detect early stages of 
the disease [20]. Thus, 3-D EIS mapping provides the 
dielectric property at the electrode-tissue interface to 
detect metabolically active atherosclerotic lesions, 
albeit angiographically invisible, for possible early 
medical intervention and prevention of acute 
coronary syndromes or stroke. 
Percutaneous transluminal coronary angioplasty 
(PTCA) – or balloon dilation of the coronary arteries – 
has been routinely performed for 40 years, initially as 
a standalone procedure [21], and subsequently 
combined with coronary stent deployment [22]. The 
safety of balloon dilation of arteries to treat 
atherosclerotic lesions is well documented in humans 
[23] and experimental models [24], with success 
determined by a post-procedure angiogram [25]. 
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Future clinical application in humans of our current 
proposed 6-point EIS sensor would similarly require 
intravascular advancement of the catheter and 
verification of balloon inflation under angiographic 
guidance, with close monitoring of impedance 
characteristics to differentiate the distinct patterns 
obtained when the sensor is only in contact with 
blood (deflated, or not fully deployed) as opposed to 
the endoluminal vessel wall (inflated, or fully 
deployed) (Fig. 6a).  
It is recognized that tissues store charges, and 
frequency-dependent electrical impedance (Z) 
develops in response to applied alternating current 
(AC). Previously proposed applications of EIS include 
assessment of cellular viability of human cancer cells 
[26] and amyloid β-sheet misfolding [27]. When an 
AC current is applied to the plaque in a vessel, a 
complex electric impedance (Z) is generated as a 
function of frequency. Z is defined as the summation 
of a resistive part  (r) and a reactive part  (Xc) 
multiplied by the complex number  (j) (𝑍𝑍 = 𝑟𝑟 + 𝑋𝑋𝑐𝑐𝑗𝑗) 
[1, 28]. Fat-free tissue is known as a good electrical 
conductor for its high water (approximately 73%) and 
electrolytes content (ions and proteins), whereas fatty 
tissue is anhydrous and a poor conductor. Thus, these 
electrical properties synergistically render a 
significantly lower electrical conductivity in lipid-rich 
plaques ( 𝜎𝜎∗ = 𝜎𝜎 + 𝑖𝑖𝑖𝑖𝑖𝑖 ; 𝜎𝜎 , 𝑖𝑖  being the intrinsic 
conductivity and permittivity of the tissue) than the 
rest of the blood and vascular components. Early 
stage lesions, though small in size and thus difficult to 
detect with conventional angiography, still exhibit a 
distinctive impedimetric behavior as opposed to 
normal arteries. These EIS properties have formed the 
electrochemical basis to detect early stage lipid-rich 
plaques.  
Several distinctive electrode configurations have 
been reported for intravascular impedimetric 
interrogation. Süselbeck et al. introduced a 
catheter-based 4-point electrode configuration to 
address the electrode-tissue contact impedance issue. 
However, its relatively large device dimension – 
required to accommodate 4 electrodes (2 cm in total 
length) – posed a clinical challenge for intravascular 
deployment [8]. We previously demonstrated the 
2-point concentric electrode configuration, providing 
a ~2000 fold reduction in device dimension (300 µm in 
diameter) to enable integration with different sensing 
modalities, including ultrasonic transducers and flow 
sensors [2, 5]. Furthermore, the concentric 
configuration addressed the heterogeneous tissue 
composition, uneven surface topography and 
non-uniform current distribution of the 
atherosclerotic lesions. Recently, we introduced the 
2-point electrode concept by implementing two 
identical flexible electrodes (240 µm in diameter) with 
a large separation (400 µm); thus, providing a deep 
current penetration for intraplaque burden detection 
[9].  
Although 4-electrode systems can be 
miniaturized to become more suitable in clinical 
applications, they still occupy twice the space of 
2-electrode systems. This issue further manifests itself 
when multiple measuring sites are required, as in the 
case of the 6-point configuration presented in the 
current study. There would be 12 electrodes needed to 
implement the equivalent for 4-electrode systems, 
thereby greatly complicating the possible electrode 
layout design as well as the electrical connections to 
the measurement instruments. Regarding the 
electrode-tissue interface impedance, as shown in Fig. 
6a there is a clear shift of the impedance value 
throughout the frequency spectrum between balloon 
deflation and inflation. These impedance values are 
composed of the interface impedance as well as the 
tissues under interrogation, thereby indicating that 
the interface impedance is dominated by the tissue 
impedance. Hence, the impedance measurement 
reflects varying responses from the underlying tissues 
(atherosclerotic plaques, aorta, etc.) and can be 
utilized in evaluating different tissue compositions. It 
is worth noting that if the electrodes were to be 
further miniaturized, thereby increasing the 
electrode-tissue interface impedance, the tissue 
impedance might not be the dominating component 
in our 2-electrode system. Further treatment, e.g. 
electroplating platinum black onto the electrode to 
reduce the interface impedance, would be necessary 
to achieve high measurement specificity. 
The aforementioned EIS sensing devices only 
focus on the local current detection that merely 
detects a small region of the entire endovascular 
segment where the atherosclerotic lesions are often 
eccentric and multiple. We further advance EIS 
sensing by implementing the 6-point configuration to 
optimize 3-D detection of small, angiographically 
invisible, atherosclerotic lesions. This unique 
configuration allowed for six stretchable electrodes to 
be circumferentially and equidistantly positioned in 
individual rows around a dilatable balloon (Fig. 1 and 
2) and were deployed in vivo in the NZW rabbit model 
of atherosclerosis. Upon balloon inflation, all 
electrodes were made possible to be in contact with 
the endoluminal surface. The elongated flexible 
polyimide electrodes eliminated the packaging 
challenge to connect the individual miniaturized 
contact pads with electrical wires for the 2-point 
sensors [9]. The addition of active electrodes (from 2 
to 6) engendered 15 different permutations to extend 
the EIS measurements from a focal region to an entire 
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circumferential ring of the aorta. Data fitting results 
using an equivalent circuit model further demonstrate 
close agreement between the experimental EIS 
measurements and theoretical equivalent circuit 
modeling (Fig. 6). The fitting results are presented in 
the supplementary information (Table S1) and we 
further performed a detailed physical modeling to 
demonstrate that our findings are in reasonable 
agreement with reported electrical properties of 
multiple tissues, thereby validating the simplified 
circuit model (Fig. S2, S3, Table S2, S3). The local EIS 
measurements were then reconstructed into 3-D 
impedimetric mapping (Fig. 4) to significantly 
enhance the visualization quality and translational 
applicability of the impedance data. 
We demonstrate that the impedance value 
distribution obtained from different combinations of 
the 6-point electrodes at a frequency of 1 kHz exhibits 
a significantly wider range in aortas of high-fat diet 
fed rabbits compared to controls on a normal diet (Fig. 
6c). This finding signifies a major characteristic shift 
from healthy arteries to ones with subclinical 
atherosclerosis and therefore can serve as a detection 
criterion. The wider range of impedance value arises 
from the fact that the existence of eccentric and 
multiple atherosclerotic lesions around the 
endoluminal surface increases the overall impedance 
variation compared to a homogeneous healthy artery. 
Previously designed EIS devices [1, 7-9] interrogated 
only limited segments of the vessel, potentially 
missing lesions which are not in close proximity with 
the electrodes. Therefore, our new 6-point 
configuration permits comprehensive 3-D mapping 
and successful detection of eccentric and small 
atherosclerotic lesions which harbor metabolically 
active lipids (Fig. 5 and 6), however remain invisible 
with conventional angiography (Fig. 3b-d).  
Conclusion 
We introduce a novel 6-point electrode design 
for early detection of subclinical atherosclerotic 
lesions. The unique electrode configuration allows for 
3 stretchable electrodes to be circumferentially and 
equidistantly positioned in individual layers. The 15 
EIS permutations provide a paradigm shift, allowing 
the reconstruction of a 3-D map of impedance 
spectroscopy. In this context, we have identified 
metabolically active plaques, also known as fatty 
streaks, that harbor lipid-laden macrophage foam 
cells [2, 3, 9, 29] that are otherwise non-detectable by 
current angiography. Thus, 3-D EIS mapping holds 
translational promises for early detection and 
prevention of acute coronary syndromes or strokes. 
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